XML 55 R40.htm IDEA: XBRL DOCUMENT
v3.22.0.1

OPERATING BUSINESS SEGMENT AND INTERNATIONAL OPERATION INFORMATION (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2021
Segment Reporting [Abstract] |
Schedule of reportable business segment information | Reportable business segment information for the years ended December 31, 2021 and 2020 is as follows (dollar amounts in thousands):
Year Ended December 31, |  | 2021 |  | 2020
Net sales: |  |  |  |
Asia |  | $ | 176,860 |  |  | $ | 138,717 |
Europe |  | 91,539 |  |  | 77,688 |
North America |  | 149,746 |  |  | 145,481 |
Latin America and Other |  | 25,939 |  |  | 23,319 |
Total net sales |  | 444,084 |  |  | 385,205 |
Contribution margin (1): |  |  |  |
Asia |  | 89,939 |  |  | 66,801 |
Europe |  | 30,959 |  |  | 26,014 |
North America |  | 56,922 |  |  | 50,193 |
Latin America and Other |  | 10,953 |  |  | 9,771 |
Total contribution margin |  | 188,773 |  |  | 152,779 |
Selling, general and administrative (2) |  | 154,103 |  |  | 131,297 |
Operating income |  | 34,670 |  |  | 21,482 |
Other income (loss), net |  | (2,848) |  |  | 1,339 |
Income before provision for income taxes |  | $ | 31,822 |  |  | $ | 22,821 |
___________________________ (1) Contribution margin consists of net sales less cost of sales and volume incentives expense. (2) Service fees in China totaled $18.7 million and $11.7 million for the years ended December 31, 2021 and 2020, respectively. These service fees are included in our selling, general and administrative expenses.
Year Ended December 31, |  | 2021 |  | 2020
Capital expenditures: |  |  |  |
Asia |  | $ | 1,081 |  |  | $ | 542 |
Europe |  | 142 |  |  | 34 |
North America |  | 5,371 |  |  | 4,267 |
Latin America and Other |  | 72 |  |  | 62 |
Total capital expenditures |  | $ | 6,666 |  |  | $ | 4,905 |
Depreciation and amortization: |  |  |  |
Asia |  | $ | 1,825 |  |  | $ | 1,919 |
Europe |  | 64 |  |  | 77 |
North America |  | 9,206 |  |  | 8,673 |
Latin America and Other |  | 67 |  |  | 74 |
Total depreciation and amortization |  | $ | 11,162 |  |  | $ | 10,743 |
As of December 31, |  | 2021 |  | 2020
Assets: |  |  |  |
Asia |  | $ | 104,659 |  |  | $ | 82,572 |
Europe |  | 15,486 |  |  | 16,398 |
North America |  | 131,207 |  |  | 142,324 |
Latin America and Other |  | 7,522 |  |  | 8,204 |
Total assets |  | $ | 258,874 |  |  | $ | 249,498 |
Schedule of consolidated net sales revenue by geographical locations | From an individual country perspective, only the United States and South Korea comprise approximately 10 percent or more of consolidated net sales for the years ended December 31, 2021 and 2020 as follows (dollar amounts in thousands):
Year Ended December 31, |  | 2021 |  | 2020
Net sales: |  |  |  |
United States |  | $ | 138,174 |  |  | $ | 134,976 |
South Korea |  | 61,107 |  |  | 62,041 |
Other |  | 244,803 |  |  | 188,188 |
Total net sales |  | $ | 444,084 |  |  | $ | 385,205 |
Schedule of revenue generated by each of the Company's product lines | Revenue generated by each of our product lines is set forth below (dollars in thousands):
Year Ended December 31, |  | 2021 |  | 2020
Asia: |  |  |  |
General health |  | $ | 50,044 |  |  | $ | 36,445 |
Immunity |  | 1,599 |  |  | 847 |
Cardiovascular |  | 48,019 |  |  | 40,496 |
Digestive |  | 36,069 |  |  | 32,605 |
Personal care |  | 17,765 |  |  | 10,606 |
Weight management |  | 23,364 |  |  | 17,718 |
|  | 176,860 |  |  | 138,717 |
Europe: |  |  |  |
General health |  | $ | 40,045 |  |  | $ | 32,822 |
Immunity |  | 8,957 |  |  | 8,231 |
Cardiovascular |  | 11,787 |  |  | 10,863 |
Digestive |  | 23,142 |  |  | 18,673 |
Personal care |  | 5,149 |  |  | 4,663 |
Weight management |  | 2,459 |  |  | 2,436 |
|  | 91,539 |  |  | 77,688 |
North America: |  |  |  |
General health |  | $ | 65,379 |  |  | $ | 61,897 |
Immunity |  | 19,563 |  |  | 23,036 |
Cardiovascular |  | 16,219 |  |  | 15,852 |
Digestive |  | 37,130 |  |  | 32,851 |
Personal care |  | 7,579 |  |  | 7,587 |
Weight management |  | 3,876 |  |  | 4,258 |
|  | 149,746 |  |  | 145,481 |
Latin America and Other: |  |  |  |
General health |  | $ | 7,532 |  |  | $ | 6,867 |
Immunity |  | 2,667 |  |  | 3,122 |
Cardiovascular |  | 2,001 |  |  | 1,512 |
Digestive |  | 10,291 |  |  | 9,863 |
Personal care |  | 2,573 |  |  | 1,203 |
Weight management |  | 875 |  |  | 752 |
|  | 25,939 |  |  | 23,319 |
Total net sales |  | $ | 444,084 |  |  | $ | 385,205 |
Schedule of consolidated property, plant and equipment by geographical locations | From an individual country perspective, only the United States comprise 10 percent or more of consolidated property, plant and equipment as follows (dollar amounts in thousands):
As of December 31 |  | 2021 |  | 2020
Property, plant and equipment, net |  |  |  |
United States |  | $ | 46,595 |  |  | $ | 50,025 |
Other |  | 4,262 |  |  | 4,330 |
Total property, plant and equipment |  | $ | 50,857 |  |  | $ | 54,355 |

X
- Definition Tabular disclosure of the names of foreign countries in which material long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets are located, and amount of such long-lived assets located in that country or foreign geographic area. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599 + Details
Name: | us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599 + Details
Name: | us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the names of foreign countries from which revenue is material and the amount of revenue from external customers attributed to those countries. An entity may also provide subtotals of geographic information about groups of countries. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599 + Details
Name: | us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration